Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.
暂无分享,去创建一个
[1] S. Dauwe,et al. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. , 1987, The American journal of pathology.
[2] R. Bast,et al. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. , 1986, Cancer research.
[3] J. Niloff,et al. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer , 1986, American journal of obstetrics and gynecology.
[4] S. Kilpatrick,et al. Role of Ca 125 as tumor marker in ovarian carcinoma , 1986, Obstetrics and gynecology.
[5] M. Leppilampi,et al. Tumor‐associated antigen Ca 125 before and during the treatment of ovarian carcinoma , 1986, Obstetrics and gynecology.
[6] U. Stenman,et al. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy , 1986, Cancer.
[7] R. Bast,et al. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. , 1984, American journal of obstetrics and gynecology.
[8] T. Klug,et al. Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bank , 1984, International journal of cancer.
[9] J. V. Nagell,et al. Tumour markers in ovarian cancer. , 1983 .
[10] T. Cr,et al. New developments in immunoperoxidase techniques and their application. , 1983, Archives of pathology & laboratory medicine.
[11] R. Bast,et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.
[12] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] M. Herlyn,et al. Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.
[14] H. Fox,et al. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary. , 1979, Journal of clinical pathology.
[15] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[16] L. Sternberger,et al. THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES , 1970, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[17] P. Gold,et al. SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.
[18] R. Kurman,et al. Contributions of Immunocytochemistry to the Diagnosis and Study of Ovarian Neoplasms , 1984, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[19] J. Douillard,et al. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA. , 1984, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[20] R. Bast,et al. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. , 1983, American journal of clinical pathology.
[21] V. Zurawski,et al. Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. , 1982 .
[22] R. Scully. Tumors of the ovary and maldeveloped gonads , 1979 .